Nature (almost) always prevails - challenging the status quo of artificial cycle frozen embryo transfers.
Artificial cycle
Assisted reproductive technologies
Frozen embryo transfer
Natural cycle
Natural proliferative phase
Journal
Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
17
07
2023
revised:
15
08
2023
accepted:
15
08
2023
pubmed:
8
10
2023
medline:
8
10
2023
entrez:
7
10
2023
Statut:
ppublish
Résumé
Frozen embryo transfers (FET) have become increasingly popular in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the implementation of the 'freeze-all' strategy. The choice between artificial or natural cycles for FET preparation has been a subject of debate, considering factors such as endometrial receptivity, flexibility of scheduling and pregnancy outcomes. While artificial cycle protocols offer convenience and flexibility, studies have suggested potential drawbacks, including higher miscarriage rates and a greater risk of hypertensive disorders during pregnancy. In contrast, natural cycle protocols involve a frequently demanding monitoring of both endometrial proliferation and follicular growth, which may lead to increased clinic visits and scheduling issues. Multiple strategies have been proposed to enhance the usage of natural cycle FET, including addressing anovulation through minimal stimulation, reducing cycle monitoring and exploring novel FET approaches. These novel approaches, such as widening the window for human chorionic gonadotrophin administration and the natural proliferative phase protocol, offer promising outcomes and increased convenience for patients. However, further research is needed to establish the optimal timing and effectiveness of these strategies. Overall, enhancing the practicality of natural cycle FETs is crucial for expanding their utilization during ART.
Identifiants
pubmed: 37804605
pii: S1472-6483(23)00452-2
doi: 10.1016/j.rbmo.2023.103352
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103352Informations de copyright
Copyright © 2023 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.